Duration of antibiotic therapy after preterm premature rupture of fetal membranes

Am J Obstet Gynecol. 2003 Sep;189(3):799-802. doi: 10.1067/s0002-9378(03)00765-8.

Abstract

Objective: This study was undertaken to compare the efficacy of 3 days versus 7 days of ampicillin in prolonging gestation for at least 7 days in women with preterm premature rupture of membranes (PPROM).

Study design: We performed a randomized clinical trial comparing 3 days of ampicillin with 7 days ampicillin in patients with PPROM. Our primary outcome was the prolongation of pregnancy for at least 7 days. Secondary outcomes included rates of chorioamnionitis, postpartum endometritis, and neonatal morbidity and mortality.

Results: Forty-eight patients were randomly selected. There was no statistically significant difference in the ability to achieve a 7-day latency (relative risk 0.83, 95% CI 0.51-1.38). In addition, there was no statistically significant difference in the rates of chorioamnionitis, endometritis, and our composite neonatal morbidity.

Conclusion: In patients with PPROM, length of antibiotic therapy does not change the rate of a 7-day latency or affect the rate of chorioamnionitis, postpartum endometritis, or neonatal morbidity.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Ampicillin / administration & dosage
  • Anti-Bacterial Agents / administration & dosage*
  • Bacterial Infections / etiology
  • Bacterial Infections / prevention & control*
  • Birth Weight
  • Chorioamnionitis / epidemiology
  • Double-Blind Method
  • Endometritis / epidemiology
  • Female
  • Fetal Membranes, Premature Rupture / complications*
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Placebos
  • Pregnancy
  • Puerperal Infection / epidemiology
  • Time Factors

Substances

  • Anti-Bacterial Agents
  • Placebos
  • Ampicillin